These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 15037214)

  • 21. Marked eosinophilia in interleukin-5 transgenic mice fails to prevent Trichinella spiralis infection.
    Hokibara S; Takamoto M; Tominaga A; Takatsu K; Sugane K
    J Parasitol; 1997 Dec; 83(6):1186-9. PubMed ID: 9406802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skin concentrations of H1-receptor antagonists.
    Simons FE; Silver NA; Gu X; Simons KJ
    J Allergy Clin Immunol; 2001 Mar; 107(3):526-30. PubMed ID: 11240955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-anaphylactic effect of Euphorbia hirta.
    Youssouf MS; Kaiser P; Tahir M; Singh GD; Singh S; Sharma VK; Satti NK; Haque SE; Johri RK
    Fitoterapia; 2007 Dec; 78(7-8):535-9. PubMed ID: 17643865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fexofenadine in horses: pharmacokinetics, pharmacodynamics and effect of ivermectin pretreatment.
    Olsén L; Ingvast-Larsson C; Larsson P; Broström H; Bondesson U; Sundqvist M; Tjälve H
    J Vet Pharmacol Ther; 2006 Apr; 29(2):129-35. PubMed ID: 16515667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of IL-4, IL-13 and IL-4Ralpha in the development of protective and pathological responses to Trichinella spiralis.
    Scales HE; Ierna MX; Lawrence CE
    Parasite Immunol; 2007 Feb; 29(2):81-91. PubMed ID: 17241396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppressive activity of fexofenadine hydrochloride on nitric oxide production in-vitro and in-vivo.
    Asano K; Kanai K; Furuta A; Furuya A; Suzaki H; Hisamitsu T
    J Pharm Pharmacol; 2007 Oct; 59(10):1389-95. PubMed ID: 17910814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term exacerbation by interleukin 13 of IgE-mediated eosinophilia in rats.
    Rossi MI; de Oliveira Barreto E; Pires AL; Rossi MI; Dias VA; Cordeiro RS; Martins MA; Lima MC
    Int Immunopharmacol; 2005 Aug; 5(9):1353-64. PubMed ID: 15953562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.
    Tashiro M; Sakurada Y; Iwabuchi K; Mochizuki H; Kato M; Aoki M; Funaki Y; Itoh M; Iwata R; Wong DF; Yanai K
    J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions between eotaxin, histamine and mast cells in early microvascular events associated with eosinophil recruitment to the site of allergic skin reactions in humans.
    Menzies-Gow A; Ying S; Phipps S; Kay AB
    Clin Exp Allergy; 2004 Aug; 34(8):1276-82. PubMed ID: 15298570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppressive activity of epinastine hydrochloride on eosinophil activation in vitro.
    Mochizuki Y; Furuta A; Furuya A; Kanai K; Asano K; Suzaki H
    In Vivo; 2008; 22(1):13-20. PubMed ID: 18396776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of E-4716, a new antihistaminic with antiallergic properties, on chemical mediators induction of immunologic reactions.
    Gutiérrez B; Dordal A; Fort M; Galicia J; Farré AJ
    Methods Find Exp Clin Pharmacol; 1996; 18(6):397-406. PubMed ID: 8892269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung eosinophilic inflammation and airway hyperreactivity are enhanced by murine anaphylactic, but not nonanaphylactic, IgG1 antibodies.
    Macedo-Soares MF; Itami DM; Lima C; Perini A; Faquim-Mauro EL; Martins MA; Macedo MS
    J Allergy Clin Immunol; 2004 Jul; 114(1):97-104. PubMed ID: 15241350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intestinal transport and catabolism of IgE: a major blood-independent pathway of IgE dissemination during a Trichinella spiralis infection of rats.
    Negrão-Corrêa D; Adams LS; Bell RG
    J Immunol; 1996 Nov; 157(9):4037-44. PubMed ID: 8892637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria.
    Thompson AK; Finn AF; Schoenwetter WF
    J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):24-30. PubMed ID: 10863219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mizolastine and fexofenadine modulate cytokine pattern after nasal allergen challenge.
    Ciprandi G; Cirillo I; Vizzaccaro A
    Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):146-50. PubMed ID: 15180356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expulsion of Trichinella spiralis from the intestine of W/Wv mice reconstituted with haematopoietic and lymphopoietic cells and origin of mucosal mast cells.
    Oku Y; Itayama H; Kamiya M
    Immunology; 1984 Oct; 53(2):337-44. PubMed ID: 6386673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fexofenadine, an H1-receptor antagonist, partially but rapidly inhibits the itch of contact dermatitis induced by diphenylcyclopropenone in patients with alopecia areata.
    Katagiri K; Arakawa S; Hatano Y; Fujiwara S
    J Dermatol; 2006 Feb; 33(2):75-9. PubMed ID: 16556272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of short- and long-term administration of verapamil on the disposition of cytochrome P450 3A and P-glycoprotein substrates.
    Lemma GL; Wang Z; Hamman MA; Zaheer NA; Gorski JC; Hall SD
    Clin Pharmacol Ther; 2006 Mar; 79(3):218-30. PubMed ID: 16513446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aggravation of bronchial eosinophilia in mice by nasal and bronchial exposure to Staphylococcus aureus enterotoxin B.
    Hellings PW; Hens G; Meyts I; Bullens D; Vanoirbeek J; Gevaert P; Jorissen M; Ceuppens JL; Bachert C
    Clin Exp Allergy; 2006 Aug; 36(8):1063-71. PubMed ID: 16911362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mast cell stabilizer ketotifen [4-(1-methyl-4-piperidylidene)-4h-benzo[4,5]cyclohepta[1,2-b]thiophen-10(9H)-one fumarate] prevents mucosal mast cell hyperplasia and intestinal dysmotility in experimental Trichinella spiralis inflammation in the rat.
    Serna H; Porras M; Vergara P
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1104-11. PubMed ID: 16988056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.